Biofil Chemicals and Pharmaceuticals Limited (NSE:BIOFILCHEM)
33.50
-0.18 (-0.53%)
Jul 22, 2026, 3:25 PM IST
NSE:BIOFILCHEM Market Cap
NSE:BIOFILCHEM has a market cap or net worth of 541.92 million as of July 22, 2026. Its market cap has decreased by -27.04% in one year.
Market Cap
541.92M
Enterprise Value
538.85M
Revenue
314.78M
Ranking
n/a
PE Ratio
19.45
Stock Price
33.50
ChartMarket Cap Chart
Since December 31, 2001, NSE:BIOFILCHEM's market cap has increased from 34.17M to 541.92M, an increase of 1,485.71%. That is a compound annual growth rate of 11.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 538.50M | -3.05% |
| Dec 31, 2025 | 555.42M | -40.49% |
| Dec 31, 2024 | 933.30M | 6.14% |
| Dec 29, 2023 | 879.27M | -2.21% |
| Dec 30, 2022 | 899.13M | -11.24% |
| Dec 31, 2021 | 1.01B | -63.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sigachi Industries | 9.56B |
| Bafna Pharmaceuticals | 5.34B |
| Valiant Laboratories | 3.45B |
| Nectar Lifesciences | 2.11B |
| Brooks Laboratories | 2.05B |
| Alpa Laboratories | 1.44B |
| Balaxi Pharmaceuticals | 1.31B |
| Par Drugs and Chemicals | 1.29B |